Victor Basse
Overview
Explore the profile of Victor Basse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanchis-Borja M, Guisier F, Swalduz A, Curcio H, Basse V, Maritaz C, et al.
Onco Targets Ther
. 2024 Jun;
17:439-448.
PMID: 38836187
Purpose: The third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), osimertinib, is an effective first-line therapy for patients with common mutation-positive non-small cell lung cancer (NSCLC). However, almost...
2.
Auliac J, Thomas P, Bylicki O, Guisier F, Curcio H, AlainVegnenegre , et al.
Ther Adv Med Oncol
. 2024 Mar;
16:17588359241236451.
PMID: 38455711
Background: Few epidemiological data are available on surgically treated Caucasian patients with non-small-cell lung cancers (NSCLCs) harboring epidermal growth factor receptor () mutations. The main objective of this study was...
3.
Dissaux G, Basse V, Schick U, Kabbaj O, Auberger B, Magro E, et al.
Medicine (Baltimore)
. 2020 Feb;
99(5):e19017.
PMID: 32000446
O-(2-[F]fluoroethyl)-L-tyrosine positron-emission tomography/computed tomography (F-FET PET/CT) is well known in brain tumor management. Our study aimed to identify the prognostic value of F-FET PET/CT in high-grade gliomas (HGG) according the...
4.
Vergnenegre A, Basse V, Le Garff G, Bylicki O, Dubos-Arvis C, Comet B, et al.
Cancer Manag Res
. 2020 Jan;
11:10821-10826.
PMID: 31920391
Background: Antiangiogenic agents have improved the prognosis of non-squamous non-small-cell lung cancers (NSCLCs), even though all the patients are not eligible to receive them because of counterindications linked to the...
5.
Basse V, Dissaux G, Seizeur R, Bourhis D, Querellou S
Clin Nucl Med
. 2018 Dec;
44(1):e22-e23.
PMID: 30540599
F-fluoroethyltyrosine (FET) is a well-established PET tracer for the imaging of cerebral gliomas. Recent studies reported interest in meningiomas. A study published by Cornelius et al concludes that FET PET...
6.
Basse V, Schick U, Gueguen P, Le Marechal C, Quintin-Roue I, Descourt R, et al.
J Thorac Oncol
. 2018 Jun;
13(7):e120-e122.
PMID: 29935850
No abstract available.